Inhibitor of Differentiation 3 Confers the Robust Anti-tumor Activity of Kupffer Cells
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Deng Z, Loyher P, Lazarov T, Li L, Shen Z, Bhinder B
. The nuclear factor ID3 endows macrophages with a potent anti-tumour activity. Nature. 2024; 626(8000):864-873.
PMC: 10881399.
DOI: 10.1038/s41586-023-06950-4.
View
2.
Mass E, Ballesteros I, Farlik M, Halbritter F, Gunther P, Crozet L
. Specification of tissue-resident macrophages during organogenesis. Science. 2016; 353(6304).
PMC: 5066309.
DOI: 10.1126/science.aaf4238.
View
3.
Wattenberg M, Coho H, Herrera V, Graham K, Stone M, Xue Y
. Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1. Sci Immunol. 2023; 8(89):eadj5097.
PMC: 11034815.
DOI: 10.1126/sciimmunol.adj5097.
View
4.
Logtenberg M, Scheeren F, Schumacher T
. The CD47-SIRPα Immune Checkpoint. Immunity. 2020; 52(5):742-752.
PMC: 7340539.
DOI: 10.1016/j.immuni.2020.04.011.
View
5.
Pathria P, Louis T, Varner J
. Targeting Tumor-Associated Macrophages in Cancer. Trends Immunol. 2019; 40(4):310-327.
DOI: 10.1016/j.it.2019.02.003.
View